Source to Sought 36C24626Q0746.pdf
PDF 215 KB Posted
- Attached to
- Industry Request for Blood Bank Analyzers
- Solicitation number
- 36C24626Q0746
About this file
This is a Sources Sought Notice issued by the Department of Veterans Affairs, Network Contracting Office 6, on behalf of Durham VA Medical Center for market research regarding blood bank analyzers.
The Durham VAMC Blood Bank seeks information about FDA-approved transfusion service analyzers utilizing GEL (gel electrophoresis) technology. The facility intends to acquire two analyzers capable of performing blood type and screen testing, forward and reverse typing, antibody screening, antibody identification panels, unit confirmation, and crossmatch testing (immediate spin and antihuman globulin phases). Direct Antiglobulin Testing (DAT) is identified as an optional capability. The current operation relies on automated GEL technology as its primary testing method, with staff expertise and familiarity in this platform, supported by a manual GEL backup system. Vendors are requested to respond by July 14, 2026 at 8:00 a.m. Eastern Time with information about their GEL technology analyzers, including brochures or technical datasheets, FDA approval specifics, company name and address, business size designation, and socioeconomic status (8(a), HUBZone, Service-Disabled Veteran-Owned, or Veteran-Owned Small Business). The response materials should also include qualifications, capabilities statements, authorized distributor documentation, and evidence of ability to meet stated requirements. This notice does not constitute a formal solicitation and the Government will not pay for any information solicited. The place of performance is Durham VA Medical Center, Durham, North Carolina 27705. The contracting officer is Patsy Simpson, reachable at Patsy.Simpson@va.gov.
View the file
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Sources Sought Notice
*= Required Field Sources Sought Notice
SUBJECT* Industry Request for Blood Bank Analyzers
GENERAL INFORMATION
CONTRACTING OFFICE’S ZIP CODE* 23667
SOLICITATION NUMBER* 36C24626Q0746
RESPONSE DATE/TIME/ZONE 07-14-2026 8:00am EASTERN TIME, NEW YORK, USA
ARCHIVE 60 DAYS AFTER THE RESPONSE DATE
RECOVERY ACT FUNDS N
SET-ASIDE
PRODUCT SERVICE CODE* 6640
NAICS CODE* 621991
CONTRACTING OFFICE ADDRESS
Department of Veterans Affairs Network Contracting Office 6 100 Emancipation Drive Hampton VA 23667
POINT OF CONTACT*
Contracting Officer Patsy Simpson Patsy.Simpson@va.gov
PLACE OF PERFORMANCE
ADDRESS Durham VA Medical Center (VAMC)
508 Fulton Street Durham NC
POSTAL CODE 27705
COUNTRY USA
ADDITIONAL INFORMATION
AGENCY’S URL
URL DESCRIPTION
AGENCY CONTACT’S EMAIL ADDRESS
EMAIL DESCRIPTION
DESCRIPTION
This notice does NOT constitute a request for proposals, request for quote, or invitation for bid. No formal solicitation document exists currently. The Government will not pay for any information solicited.
The Department of Veterans Affairs Medical Center, Network Contracting Office (NCO) 6, on behalf of the Durham VA Medical Center, is conducting market research for the purchase of blood bank analyzers.
Background The Durham VA Medical Center (VAMC) Blood Bank currently utilizes automated GEL technology as its primary mode of blood bank testing. This technology is preferred due to:
Established staff knowledge and extensive education in GEL testing methods Comfort and familiarity with automated GEL technology for daily operations Consistency ensured with a manual GEL backup system, which aligns test result interpretation with the automated GEL system
Purpose The Durham VAMC is seeking information from industry partners regarding available FDA-approved transfusion service analyzers. These analyzers will support continued GEL-based testing within the blood bank, facilitating operational continuity and high-quality patient care.
Requirements The Durham VAMC Blood Bank is seeking acquisition of two transfusion service analyzers, both FDA-approved, that must be capable of performing the following tests:
Blood type and screen testing Forward and reverse typing Antibody screening Antibody identification panels Unit confirmation Crossmatch testing (both immediate spin and AHG [Antihuman Globulin] phases)
Optional Capability:
Direct Antiglobulin Testing (DAT)
Industry Day Goals The Durham VAMC requests information from vendors regarding their products’ abilities to meet the above requirements, specifically with respect to GEL technology. The virtual industry day will serve as a forum to:
Explain current blood bank workflows and testing needs Receive technical presentations from vendors on analyzer capabilities Discuss operational integration and training requirements Address questions about compatibility with VA infrastructure
Submission Instructions Interested vendors are asked to respond with:
Information about GEL technology analyzers that meet the stated requirements Brochures or technical datasheets describing product features Specifics regarding FDA approval
Responses to this source sought notice should include the following: name and address of company, business size (large or small): identify whether or not firm falls into any of the following socioeconomic categories-8(a), HUBZone, Services Disabled Veteran-Owned/Veteran-Owned Small Business; provide a brief description of qualifications, capabilities statement, authorized distributor documentation, and any other pertinent information which demonstrates the ability to meet the above requirement.
File details come from the government source that posted it. Updated .